CD226 anticorps (C-Term) (FITC)
-
- Antigène Voir toutes CD226 Anticorps
- CD226
-
Épitope
- AA 306-335, C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CD226 est conjugé à/à la FITC
-
Application
- Western Blotting (WB), ELISA
- Réactivité croisée
- Humain
- Réactivité croisée (Details)
- Calculated cross reactivity: Hu
- Attributs du produit
- CD226, CT (CD226, DNAM1, CD226 antigen, DNAX accessory molecule 1, CD226) (FITC)
- Purification
- Purified by Protein A affinity chromatography.
- Immunogène
- CD226 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 306-335 amino acids from the C-terminal region of human CD226.
- Isotype
- IgG
- Top Product
- Discover our top product CD226 Anticorps primaire
-
-
- Indications d'application
- Optimal working conditions should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2.
- Stock
- -20 °C
- Stockage commentaire
- -20°C
-
- Antigène
- CD226
- Autre désignation
- CD226 (CD226 Produits)
- Synonymes
- anticorps CD226, anticorps cd226, anticorps zgc:158817, anticorps BC051526, anticorps DNAM-1, anticorps DNAM1, anticorps Pta1, anticorps TLiSA1, anticorps PTA1, anticorps CD226 molecule, anticorps CD226 antigen, anticorps CD226, anticorps cd226, anticorps Cd226
- NCBI Accession
- NP_006557
- UniProt
- Q15762
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-